thalidomide has been researched along with Myelolipoma in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Myelolipoma: A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heuck, CJ | 1 |
| Szymonifka, J | 1 |
| Hansen, E | 1 |
| Shaughnessy, JD | 1 |
| Usmani, SZ | 1 |
| van Rhee, F | 1 |
| Anaissie, E | 1 |
| Nair, B | 1 |
| Waheed, S | 1 |
| Alsayed, Y | 1 |
| Petty, N | 1 |
| Bailey, C | 1 |
| Epstein, J | 1 |
| Hoering, A | 1 |
| Crowley, J | 1 |
| Barlogie, B | 1 |
1 trial available for thalidomide and Myelolipoma
| Article | Year |
|---|---|
Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1.
Topics: Aged; Biomarkers, Pharmacological; Disease-Free Survival; Female; Gene Expression Regulation, Neopla | 2012 |